These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24702005)

  • 1. Fluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer's disease.
    He XP; Deng Q; Cai L; Wang CZ; Zang Y; Li J; Chen GR; Tian H
    ACS Appl Mater Interfaces; 2014 Apr; 6(8):5379-82. PubMed ID: 24702005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid.
    Kanekiyo T; Ban T; Aritake K; Huang ZL; Qu WM; Okazaki I; Mohri I; Murayama S; Ozono K; Taniike M; Goto Y; Urade Y
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6412-7. PubMed ID: 17404210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, orientation, and surface interaction of Alzheimer amyloid-β peptides on the graphite.
    Yu X; Wang Q; Lin Y; Zhao J; Zhao C; Zheng J
    Langmuir; 2012 Apr; 28(16):6595-605. PubMed ID: 22468636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease.
    Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM
    Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease.
    Gunn AP; Masters CL; Cherny RA
    Int J Biochem Cell Biol; 2010 Dec; 42(12):1915-8. PubMed ID: 20833262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides.
    Yu Y; Zhang L; Li C; Sun X; Tang D; Shi G
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12832-5. PubMed ID: 25244702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease.
    Zetterberg H; Blennow K
    Alzheimers Dement; 2013 Jul; 9(4):459-62. PubMed ID: 23159047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer.
    Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI
    J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease.
    Salvadores N; Shahnawaz M; Scarpini E; Tagliavini F; Soto C
    Cell Rep; 2014 Apr; 7(1):261-8. PubMed ID: 24656814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graphene oxide strongly inhibits amyloid beta fibrillation.
    Mahmoudi M; Akhavan O; Ghavami M; Rezaee F; Ghiasi SM
    Nanoscale; 2012 Dec; 4(23):7322-5. PubMed ID: 23079862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metallobiology of Alzheimer's disease.
    Bush AI
    Trends Neurosci; 2003 Apr; 26(4):207-14. PubMed ID: 12689772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.
    Marambaud P; Zhao H; Davies P
    J Biol Chem; 2005 Nov; 280(45):37377-82. PubMed ID: 16162502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic implications of gelsolin in Alzheimer's disease.
    Ji L; Zhao X; Hua Z
    J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?
    Timmer NM; Kuiperij HB; de Waal RM; Verbeek MM
    J Alzheimers Dis; 2010; 22(2):345-55. PubMed ID: 20847441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of resveratrol to monomer and fibril amyloid beta.
    Ge JF; Qiao JP; Qi CC; Wang CW; Zhou JN
    Neurochem Int; 2012 Dec; 61(7):1192-201. PubMed ID: 22981725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.